HOME >> MEDICINE >> NEWS
Detection of antibodies could identify MS pats who do not respond well to interferon beta

Danish research published in this week's issue of THE LANCET highlights how the detection of antibodies to interferon beta-the first choice treatment for multiple sclerosis patients-could be important in identifying patients who do not respond well to interferon beta, with implications for the provision of alternative drug therapy.

Interferon beta is the first-line treatment for relapsing-remitting multiple sclerosis, but the drug can induce neutralising antibodies against itself, which might reduce its effectiveness. Per Soelberg Sorensen from Copenhagen University Hospital, Denmark, and colleagues measured neutralising antibodies every year for up to five years among 541 patients with multiple sclerosis, randomly selected from all patients who started treatment with interferon beta in Denmark between 1996 and 1999.

The time to first relapse was substantially longer (by 244 days) for patients who were antibody-negative after one year of interferon-beta treatment compared with patients who were antibody-positive. The yearly relapse rate was increased more than 50% in patients who developed antibodies compared with those who did not.

Patients developed neutralising antibodies independent of age, sex, disease duration, and prognosis at the start of treatment. The presence of antibodies did not affect overall disease outcome.

Per Soelberg Sorensen comments: "Our findings suggest that the presence of neutralising antibodies against interferon beta reduces the clinical effect of the drug. In patients who are not doing well on interferon beta, the presence of such antibodies should prompt consideration about a change of treatment to other drug therapies such as glatiramer acetate or mitoxantrone."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
9-Oct-2003


Page: 1

Related medicine news :

1. Detection at a distance for more sensitive MRI
2. Detection of glycoprotein could indentify ovarian and uterine cancers with poor prognosis
3. Detection of bioterrorism viruses brought closer to local sites
4. Detection of glucose intolerance after heart attack
5. Detection of glucose intolerance after heart attack could identify risk of cardiovascular disease
6. Millions Of Americans With Glaucoma Could Save Sight With Early Detection, Treatment
7. Microwaves May Provide Early Detection Of Breast Cancer
8. Learning From Experience: New Pattern Recognition & Detection Helps Radiologists Analyze Digital Mammograms
9. Could autoantibodies predict future disease in healthy people?
10. Mouse antibodies thwart SARS virus
11. Autoantibodies precede disease in lupus patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Texas , Oct. 11, 2017  Caris Life ... focused on fulfilling the promise of precision medicine, today ... has joined Caris, Precision Oncology Alliance™ (POA) as its ... cancer centers, the St. Jude Crosson Cancer Institute will ... advance the use of tumor profiling, making cancer treatment ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/4/2017)... -- According to the Centers for Disease Control and Prevention (CDC), influenza ... Care is helping communities across Massachusetts , ... no-cost* flu shots through the end of the month. *Some ... ... flu shot is by the end of October, according to the Centers ...
Breaking Medicine Technology:
Cached News: